Influenza vaccines: an Asia-Pacific perspective

Influenza-associated mortality in temperate and subtropical Chinese cities, 2003–2008

(2014) Luzhao Feng et al.   BULLETIN OF THE WORLD HEALTH ORGANIZATION

Vero cell culture-derived pandemic influenza vaccines: preclinical and clinical development

(2013) P Noel Barrett et al.   Expert Review of Vaccines

Major Challenges in Providing an Effective and Timely Pandemic Vaccine for Influenza A(H7N9)

(2013) Michael T. Osterholm et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Comparison of four multiplex PCR assays for the detection of viral pathogens in respiratory specimens

(2013) Trevor P. Anderson et al.   JOURNAL OF VIROLOGICAL METHODS

Human Infection with a Novel Avian-Origin Influenza A (H7N9) Virus

(2013) Rongbao Gao et al.   NEW ENGLAND JOURNAL OF MEDICINE

A Review of the Evidence to Support Influenza Vaccine Introduction in Countries and Areas of WHO's Western Pacific Region

(2013) Gina Samaan et al.   PLoS One

Corrigendum to “The economic value of a quadrivalent versus trivalent influenza vaccine” [Vaccine 30 (2012) 7443–7446]

(2013) Bruce Y. Lee et al.   VACCINE

Report on the first WHO integrated meeting on development and clinical trials of influenza vaccines that induce broadly protective and long-lasting immune responses

(2013) Marc P. Girard et al.   VACCINE

H5N1 vaccines in humans

(2013) Mariana Baz et al.   VIRUS RESEARCH

Effectiveness of Adjuvanted Influenza Vaccination in Elderly Subjects in Northern Italy

(2012) S. Mannino et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY

Neonatal outcomes after influenza immunization during pregnancy: a randomized controlled trial

(2012) M. C. Steinhoff et al.   CANADIAN MEDICAL ASSOCIATION JOURNAL

Review: interventions to increase influenza vaccination among healthcare workers in hospitals

(2012) Helge Hollmeyer et al.   Influenza and Other Respiratory Viruses

Epidemiological and Virological Characteristics of Influenza in the Western Pacific Region of the World Health Organization, 2006–2010

(2012)   PLoS One

Influenza Vaccination Guidelines and Vaccine Sales in Southeast Asia: 2008–2011

(2012) Vinay Gupta et al.   PLoS One

The economic value of a quadrivalent versus trivalent influenza vaccine

(2012) Bruce Y. Lee et al.   VACCINE

Report of the 5th meeting on influenza vaccines that induce broad spectrum and long-lasting immune responses, World Health Organization, Geneva, 16–17 November 2011

(2012) Bethan Hughes et al.   VACCINE

Public health impact of including two lineages of influenza B in a quadrivalent seasonal influenza vaccine

(2012) Carrie Reed et al.   VACCINE

Technology transfer of an oil-in-water vaccine-adjuvant for strengthening pandemic influenza preparedness in Indonesia

(2012) Roland Ventura et al.   VACCINE

Global production capacity of seasonal influenza vaccine in 2011

(2012) Jeffrey Partridge et al.   VACCINE

The rationale for quadrivalent influenza vaccines

(2012) Christopher S. Ambrose et al.   Human Vaccines & Immunotherapeutics

Impact of maternal immunization on influenza hospitalizations in infants

(2011) Katherine A. Poehling et al.   AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY

Effect of respiratory hospitalization during pregnancy on infant outcomes

(2011) Shelly A. McNeil et al.   AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY

New approaches for influenza vaccination of healthcare workers

(2011) James G. Johnson et al.   CURRENT OPINION IN INFECTIOUS DISEASES

Cell-culture-derived influenza vaccine production

(2011) W Paul Glezen   LANCET

Efficacy, safety, and immunogenicity of a Vero-cell-culture-derived trivalent influenza vaccine: a multicentre, double-blind, randomised, placebo-controlled trial

(2011) P Noel Barrett et al.   LANCET

Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis

(2011) Michael T Osterholm et al.   LANCET INFECTIOUS DISEASES

Oil-in-Water Emulsion Adjuvant with Influenza Vaccine in Young Children

(2011) Timo Vesikari et al.   NEW ENGLAND JOURNAL OF MEDICINE

A Neutralizing Antibody Selected from Plasma Cells That Binds to Group 1 and Group 2 Influenza A Hemagglutinins

(2011) D. Corti et al.   SCIENCE

WHO initiative to increase global and equitable access to influenza vaccine in the event of a pandemic: Supporting developing country production capacity through technology transfer

(2011) Martin Friede et al.   VACCINE

Seasonal influenza vaccine provision in 157 countries (2004–2009) and the potential influence of national public health policies

(2011) Abraham Palache   VACCINE

Establishment of pandemic influenza vaccine production capacity at Bio Farma, Indonesia

(2011) Mahendra Suhardono et al.   VACCINE

Development of pandemic influenza vaccine production capacity in Viet Nam

(2011) L.K. Hoa et al.   VACCINE

Effectiveness and safety of influenza vaccination in children: European perspective

(2011) Terho Heikkinen et al.   VACCINE

Development of influenza vaccine production capacity by the Government Pharmaceutical Organization of Thailand: Addressing the threat of an influenza pandemic

(2011) Somchaiya Surichan et al.   VACCINE

Evaluation of the safety, reactogenicity and immunogenicity of FluBlok® trivalent recombinant baculovirus-expressed hemagglutinin influenza vaccine administered intramuscularly to healthy adults 50–64 years of age☆

(2011) R. Baxter et al.   VACCINE

Protective efficacy of a trivalent recombinant hemagglutinin protein vaccine (FluBlok®) against influenza in healthy adults: A randomized, placebo-controlled trial

(2011) John J. Treanor et al.   VACCINE

Clinical development of a Vero cell culture-derived seasonal influenza vaccine

(2011) Hartmut J. Ehrlich et al.   VACCINE

The efficacy of intranasal live attenuated influenza vaccine in children 2 through 17 years of age: A meta-analysis of 8 randomized controlled studies

(2011) Christopher S. Ambrose et al.   VACCINE

Maternal Influenza Immunization and Reduced Likelihood of Prematurity and Small for Gestational Age Births: A Retrospective Cohort Study

(2011) Saad B. Omer et al.   PLOS MEDICINE

Risk Factors for Severe Outcomes following 2009 Influenza A (H1N1) Infection: A Global Pooled Analysis

(2011) Maria D. Van Kerkhove et al.   PLOS MEDICINE

Maternal Influenza Vaccination and Effect on Influenza Virus Infection in Young Infants

(2010) Angelia A. Eick et al.   ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE

Influenza Vaccine Given to Pregnant Women Reduces Hospitalization Due to Influenza in Their Infants

(2010) Isaac Benowitz et al.   CLINICAL INFECTIOUS DISEASES

Mandatory Influenza Vaccination of Health Care Workers: Translating Policy to Practice

(2010) Hilary M. Babcock et al.   CLINICAL INFECTIOUS DISEASES

Clinical Efficacy of Cell Culture–Derived and Egg‐Derived Inactivated Subunit Influenza Vaccines in Healthy Adults

(2010) Sharon Frey et al.   CLINICAL INFECTIOUS DISEASES

Repeated vaccination is required to optimize seroprotection against H1N1 in the immunocompromised host

(2010) H. de Lavallade et al.   HAEMATOLOGICA

Mandatory Influenza Vaccination of Healthcare Workers: A 5-Year Study

(2010) Robert M. Rakita et al.   INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY

The relative efficacy of trivalent live attenuated and inactivated influenza vaccines in children and adults

(2010) Christopher S. Ambrose et al.   Influenza and Other Respiratory Viruses

Report of the fourth meeting on ‘Influenza vaccines that induce broad spectrum and long-lasting immune responses’, World Health Organization and Wellcome Trust, London, United Kingdom, 9–10 November 2009

(2010) Iain Stephenson et al.   VACCINE

2005 and 2006 seasonal influenza vaccination coverage rates in 10 countries in Africa, Asia Pacific, Europe, Latin America and the Middle East

(2009) Camille de Lataillade et al.   JOURNAL OF PUBLIC HEALTH POLICY

Comparative Efficacy of Inactivated and Live Attenuated Influenza Vaccines

(2009) Arnold S. Monto et al.   NEW ENGLAND JOURNAL OF MEDICINE

Evaluation of the safety, reactogenicity and immunogenicity of FluBlok® trivalent recombinant baculovirus-expressed hemagglutinin influenza vaccine administered intramuscularly to healthy children aged 6–59 months

(2009) James C. King et al.   VACCINE

Prevention of Symptomatic Seasonal Influenza in 2005–2006 by Inactivated and Live Attenuated Vaccines

(2008) Suzanne E. Ohmit et al.   JOURNAL OF INFECTIOUS DISEASES

Global trends in emerging infectious diseases

(2008) Kate E. Jones et al.   NATURE

Effectiveness of Maternal Influenza Immunization in Mothers and Infants

(2008) K. Zaman et al.   NEW ENGLAND JOURNAL OF MEDICINE

The Global Circulation of Seasonal Influenza A (H3N2) Viruses

(2008) C. A. Russell et al.   SCIENCE